The U.S. Supreme Court has blocked any changes to mifepristone regulations, maintaining nationwide access to the drug while the Louisiana v. FDA litigation and other state challenges proceed through the courts

From the articleFDA says it will complete safety review of abortion pill in MarchAlso in FDA says its review of abortion pill will continue into next year, FDA says its review of abortion pill will continue into next year, FDA's abortion pill safety review continuing into next year angers abortion rights opponents, FDA says its safety review of abortion pill will continue into next year | CNN